9th May 2006 07:00
Futura Medical PLC09 May 2006 For immediate release 9 May 2006 Futura Medical plc Update on MED2002 Futura Medical plc (AIM: FUM), the pharmaceutical drug and medical device groupthat develops innovative products for sexual health, announces that it has beenadvised by the major global pharmaceutical group (MGPG) that the formal approvalprocess is in its final stage. James Barder, Futura's Chief Executive, said: "We are informed by MGPG thatMED2002 remains a high priority for them." For further information:Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 845 670mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court Tel: +44 (0) 20 7466 5000 Futura Medical plc Futura Medical is an AIM-listed pharmaceutical drug and medical device groupdeveloping innovative products for sexual health. The Company is developing aportfolio of products with the intention of licensing their manufacture anddistribution to major pharmaceutical and healthcare groups. Exclusiveworldwide distribution agreements have already been signed in respect ofFutura's two condom safety products, CSD500 and FLD500, with SSL Internationalplc, the makers of DurexTM condoms. Futura's primary focus is on Over the Counter (OTC) products with particularappeal to men and women who are reluctant to discuss potentially embarrassingsexual matters with their doctors. For further information please visit: www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Futura Medical